ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,609,363 | +673.8% | 144,079 | +1382.4% | 0.00% | – |
| Q2 2023 | $207,987 | -74.5% | 9,719 | -51.9% | 0.00% | – |
| Q1 2023 | $816,322 | +245.9% | 20,186 | +539.4% | 0.00% | – |
| Q4 2021 | $236,000 | -62.6% | 3,157 | -71.6% | 0.00% | – |
| Q3 2021 | $631,000 | +58.1% | 11,100 | +22.5% | 0.00% | – |
| Q2 2021 | $399,000 | +99.5% | 9,060 | +90.6% | 0.00% | – |
| Q4 2020 | $200,000 | -24.2% | 4,753 | -17.6% | 0.00% | – |
| Q3 2020 | $264,000 | +26.9% | 5,767 | +39.5% | 0.00% | – |
| Q2 2020 | $208,000 | -30.2% | 4,135 | -14.3% | 0.00% | – |
| Q4 2019 | $298,000 | -15.6% | 4,826 | -17.9% | 0.00% | -100.0% |
| Q3 2019 | $353,000 | +69.7% | 5,880 | +138.8% | 0.00% | – |
| Q2 2019 | $208,000 | -45.3% | 2,462 | -54.1% | 0.00% | -100.0% |
| Q4 2018 | $380,000 | -63.6% | 5,364 | -40.4% | 0.00% | -50.0% |
| Q2 2018 | $1,043,000 | +340.1% | 9,000 | +50.5% | 0.00% | 0.0% |
| Q3 2014 | $237,000 | -49.3% | 5,981 | -44.9% | 0.00% | -66.7% |
| Q2 2014 | $467,000 | – | 10,851 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |